Sam leads a team focused on modernising and adapting clinical trials and pharmaceutical operations. This includes areas such as adding technology to trials to bring better and more meaningful data; how we find and interact with patients in clinical research; how trials are run and where – in order to increase access and representation; as well as other aspects of patient centricity and trial decentralization.